Financials
Financial year 2025
PATHOSENSE from Lier, company number BE0755557744, closed financial year 2025 with a result of € 94,137 after tax. For that financial year PATHOSENSE recorded a gross margin of € 692,475 and equity of € 157,114. Compared with financial year 2024, the result moved from € 72,723 to € 94,137. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 27, 2026.
€ 157,114
▲ 149% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 94,137
▲ 29% vs 2024
Profit after tax over the fiscal year.
€ 221,036
▲ 128% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 142,114.
People and assets in 2025
€ 455,656
▲ 22% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 34,468
▲ 253% vs 2024
Of which on lease € 28,008.
Debts at end 2025
€ 522,390
▼ 4% vs 2024
€ 91,471 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 74,604
▲ 199% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 142,109
▲ 85% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 278,349 | € 406,973 | € 542,020 | € 692,475 | ▲ 28% |
| Profit after taxes | € 2,412 | € 65,864 | € 72,723 | € 94,137 | ▲ 29% |
| Equity | € -75,562 | € -9,745 | € 62,977 | € 157,114 | ▲ 149% |
| Total debts | € 506,425 | € 483,249 | € 811,649 | € 1,048,109 | ▲ 29% |
| Cash | € 207,491 | € 31,093 | € 96,854 | € 221,036 | ▲ 128% |
| Retained profit | € -90,562 | € -24,745 | € 47,977 | € 142,114 | ▲ 196% |
| Bank debt | € 413,779 | € 363,073 | € 545,822 | € 522,390 | ▼ 4% |
| Balance sheet total | € 430,863 | € 473,504 | € 874,626 | € 1,205,223 | ▲ 38% |
Key figures of PATHOSENSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PATHOSENSE?
What happened at PATHOSENSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 94,137 (▲ 29% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- New establishment in Lier. KBO
- Start of the company according to the CBE. KBO
In short
From € 2,412 profit in 2022 to € 94,137 profit in 2025.
Best year ever: 2025, with € 94,137 profit.
Management
Behind PATHOSENSE are Hans Nauwynck and Theuns Sebastiaan.
Directors
According to the 2025 annual accounts
Hans Nauwynck
Director
Theuns Sebastiaan
Director
Establishments
Establishment units
Physical locations of this company
Pastoriestraat 10
2500 Lier
Poortakkerstraat 41
9051 Gent
Active since 1 October 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0755.557.744
- VAT number
- BE 0755.557.744
- Registered office
- Pastoriestraat 10, 2500 Lier
- Names & denominations
- PATHOSENSE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 October 2020
- Peppol
- Active · Active since 27 Jan 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Veterinaire diensten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied